MMP2 and neoplasm: In conclusion, the present study demonstrated that the OSCC invasive subtype SCC stromal cell xenograft promoted the higher localization of BMDCs to the invasive front line of the tumor and the expression of MMP2 compared to the less-invasive subtype—the VSCC stromal cell xenograft.